These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 27141423)

  • 1. HIV and viral protein effects on the blood brain barrier.
    McRae M
    Tissue Barriers; 2016; 4(1):e1143543. PubMed ID: 27141423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of HIV-1 Tat and Methamphetamine on Blood-Brain Barrier Integrity and Function
    Patel S; Leibrand CR; Palasuberniam P; Couraud PO; Weksler B; Jahr FM; McClay JL; Hauser KF; McRae M
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical and Metabolic Integrity of the Blood-Brain Barrier in HIV Infection: A Special Focus on Intercellular Junctions, Influx and Efflux Transporters and Metabolizing Enzymes.
    Shawahna R
    Curr Drug Metab; 2015; 16(2):105-23. PubMed ID: 26179607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactive role of human immunodeficiency virus type 1 (HIV-1) clade-specific Tat protein and cocaine in blood-brain barrier dysfunction: implications for HIV-1-associated neurocognitive disorder.
    Gandhi N; Saiyed ZM; Napuri J; Samikkannu T; Reddy PV; Agudelo M; Khatavkar P; Saxena SK; Nair MP
    J Neurovirol; 2010 Jul; 16(4):294-305. PubMed ID: 20624003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV Tat-mediated induction of autophagy regulates the disruption of ZO-1 in brain endothelial cells.
    Liao K; Niu F; Hu G; Guo ML; Sil S; Buch S
    Tissue Barriers; 2020 Apr; 8(2):1748983. PubMed ID: 32299282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Junctional proteins of the blood-brain barrier: New insights into function and dysfunction.
    Stamatovic SM; Johnson AM; Keep RF; Andjelkovic AV
    Tissue Barriers; 2016; 4(1):e1154641. PubMed ID: 27141427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Permeability of the blood-brain barrier to HIV-1 Tat.
    Banks WA; Robinson SM; Nath A
    Exp Neurol; 2005 May; 193(1):218-27. PubMed ID: 15817280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 gp120 compromises blood-brain barrier integrity and enhances monocyte migration across blood-brain barrier: implication for viral neuropathogenesis.
    Kanmogne GD; Schall K; Leibhart J; Knipe B; Gendelman HE; Persidsky Y
    J Cereb Blood Flow Metab; 2007 Jan; 27(1):123-34. PubMed ID: 16685256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection.
    Abdullahi W; Tripathi D; Ronaldson PT
    Am J Physiol Cell Physiol; 2018 Sep; 315(3):C343-C356. PubMed ID: 29949404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burns Impair Blood-Brain Barrier and Mesenchymal Stem Cells Can Reverse the Process in Mice.
    Yang J; Ma K; Zhang C; Liu Y; Liang F; Hu W; Bian X; Yang S; Fu X
    Front Immunol; 2020; 11():578879. PubMed ID: 33240266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis.
    Dallasta LM; Pisarov LA; Esplen JE; Werley JV; Moses AV; Nelson JA; Achim CL
    Am J Pathol; 1999 Dec; 155(6):1915-27. PubMed ID: 10595922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 Tat and opioids act independently to limit antiretroviral brain concentrations and reduce blood-brain barrier integrity.
    Leibrand CR; Paris JJ; Jones AM; Masuda QN; Halquist MS; Kim WK; Knapp PE; Kashuba ADM; Hauser KF; McRae M
    J Neurovirol; 2019 Aug; 25(4):560-577. PubMed ID: 31102185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of blood-brain barrier: effects of HIV Tat on brain microvascular endothelial cells and tight junction proteins.
    Sun Y; Cai M; Liang Y; Zhang Y
    J Neurovirol; 2023 Dec; 29(6):658-668. PubMed ID: 37899420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fentanyl dysregulates neuroinflammation and disrupts blood-brain barrier integrity in HIV-1 Tat transgenic mice.
    Rademeyer KM; R Nass S; Jones AM; Ohene-Nyako M; Hauser KF; McRae M
    J Neurovirol; 2024 Feb; 30(1):1-21. PubMed ID: 38280928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methamphetamine alters blood brain barrier permeability via the modulation of tight junction expression: Implication for HIV-1 neuropathogenesis in the context of drug abuse.
    Mahajan SD; Aalinkeel R; Sykes DE; Reynolds JL; Bindukumar B; Adal A; Qi M; Toh J; Xu G; Prasad PN; Schwartz SA
    Brain Res; 2008 Apr; 1203():133-48. PubMed ID: 18329007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral interactions with the blood-brain barrier: old dog, new tricks.
    Hou J; Baker LA; Zhou L; Klein RS
    Tissue Barriers; 2016; 4(1):e1142492. PubMed ID: 27141421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excess soluble CD40L contributes to blood brain barrier permeability in vivo: implications for HIV-associated neurocognitive disorders.
    Davidson DC; Hirschman MP; Sun A; Singh MV; Kasischke K; Maggirwar SB
    PLoS One; 2012; 7(12):e51793. PubMed ID: 23251626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the link between neurotropic viruses, BBB permeability, and MS pathogenesis.
    Rani A; Ergün S; Karnati S; Jha HC
    J Neurovirol; 2024 Feb; 30(1):22-38. PubMed ID: 38189894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired immunodeficiency syndrome and the blood-brain barrier.
    Ivey NS; MacLean AG; Lackner AA
    J Neurovirol; 2009 Apr; 15(2):111-22. PubMed ID: 19306229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tight junction modulation of the blood brain barrier: CNS delivery of small molecules.
    Greene C; Campbell M
    Tissue Barriers; 2016; 4(1):e1138017. PubMed ID: 27141420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.